These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8585264)

  • 1. Interrelation between atherosclerosis and restenosis.
    Kranzhöfer R; Libby P
    Z Kardiol; 1995; 84 Suppl 4():125-8. PubMed ID: 8585264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Letter by Brugaletta et al. regarding article, "Interference of drug-eluting stents and endothelium-dependent coronary vasomotion: evidence for device-specific responses".
    Brugaletta S; Yuste VM; Sabaté M
    Circ Cardiovasc Interv; 2009 Apr; 2(2):e1; author reply e2. PubMed ID: 20031697
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary angioplasty and coronary artery remodeling.
    Silva Orrego P; Belli G; Klugmann S
    Cardiologia; 1999 Jul; 44(7):621-5. PubMed ID: 10476586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restenosis following percutaneous transluminal angioplasty: clinical, physiologic and pathological features.
    Cox JL; Gotlieb AI
    CMAJ; 1986 May; 134(10):1129-32. PubMed ID: 2938706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vessel wall reaction in restenosis.
    Schwartz RS
    Semin Interv Cardiol; 1997 Jun; 2(2):83-8. PubMed ID: 9546996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathophysiology and pathobiochemistry of restenosis].
    Höfling B; Gonschior P; Nikol S; Bauriedel G; Welsch U; Nerlich A
    Z Kardiol; 1994 May; 83(5):313-8. PubMed ID: 8053238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on PTCA: what are its limitations? Can they be overcome by new devices? A look at atherectomy, intra-arterial stents, and laser catheters.
    Feldman T; Moscucci M
    J Crit Illn; 1993 Apr; 8(4):461-78. PubMed ID: 10148463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Coronary circulation].
    Leinonen H
    Duodecim; 1998; 114(17):1753-62. PubMed ID: 11717784
    [No Abstract]   [Full Text] [Related]  

  • 9. Thoughts about PTCA and the problem of restenosis.
    Lemire GG
    Clin Cardiol; 1991 Jan; 14(1):1. PubMed ID: 2019024
    [No Abstract]   [Full Text] [Related]  

  • 10. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of polymorphonuclear leukocyte adhesion molecules and its clinical significance in patients treated with percutaneous transluminal coronary angioplasty.
    Inoue T; Sakai Y; Morooka S; Hayashi T; Takayanagi K; Takabatake Y
    J Am Coll Cardiol; 1996 Nov; 28(5):1127-33. PubMed ID: 8890805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of inflammation in plaque disruption and thrombosis.
    Chyu KY; Shah PK
    Rev Cardiovasc Med; 2001; 2(2):82-91. PubMed ID: 12439385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
    Patti G; Melfi R; Di Sciascio G
    Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [-Anticoagulation after intracoronary stent implantation-].
    Bode C; Nordt TK; Kübler W
    Herz; 1996 Feb; 21(1):60-3. PubMed ID: 8647580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of restenosis after percutaneous transluminal coronary angioplasty using coronary flow reserve. Kansai Doppler Guide Wire Study Group].
    Toda I; Teragaki M; Nishida Y; Kobayashi Y; Shimada K; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
    J Cardiol; 2000 Mar; 35(3):165-73. PubMed ID: 10808423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions.
    Kipshidze N; Dangas G; Tsapenko M; Moses J; Leon MB; Kutryk M; Serruys P
    J Am Coll Cardiol; 2004 Aug; 44(4):733-9. PubMed ID: 15312851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to study the effects of platelet aggregation and thrombosis on coronary vasomotion and their clinical relevance.
    Golino P; Crea F; Willerson JT
    Ital Heart J; 2002 Apr; 3(4):220-5. PubMed ID: 12025369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitatively assessed coronary collateral circulation and restenosis following percutaneous revascularization.
    Wahl A; Billinger M; Fleisch M; Meier B; Seiler C
    Eur Heart J; 2000 Nov; 21(21):1776-84. PubMed ID: 11052842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The three processes leading to post PTCA restenosis: dependence on the lesion substrate.
    Fuster V; Falk E; Fallon JT; Badimon L; Chesebro JH; Badimon JJ
    Thromb Haemost; 1995 Jul; 74(1):552-9. PubMed ID: 8578523
    [No Abstract]   [Full Text] [Related]  

  • 20. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology.
    Kern MJ; Lerman A; Bech JW; De Bruyne B; Eeckhout E; Fearon WF; Higano ST; Lim MJ; Meuwissen M; Piek JJ; Pijls NH; Siebes M; Spaan JA;
    Circulation; 2006 Sep; 114(12):1321-41. PubMed ID: 16940193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.